nVerses Capital’s Xylem XYL Stock Holding History

nVerses Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,457	Closed	-$335K	–	488
2025 Q4	$335K	Buy	+2,457	New	+$353K	0.75%	25
2024 Q3	–	Sell	-2,600	Closed	-$353K	–	1427
2024 Q2	$353K	Buy	+2,600	New	+$354K	0.21%	156

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

nVerses Capital's XYL Position: Q1 2026 in Review

nVerses Capital sold out of Xylem (XYL) in Q1 2026, closing a stake of 2,457 shares — an estimated $335K sold.

nVerses Capital first reported a position in XYL in Q2 2024 and held it in 2 quarters. The position peaked at $353K in Q2 2024. 1,110 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

nVerses Capital reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
nVerses Capital sold 2,457 Xylem shares in Q1 2026, an estimated $335K.
nVerses Capital first reported a position in Xylem in Q2 2024 and held it in 2 quarters.
nVerses Capital's Xylem position peaked at $353K in Q2 2024.
1,110 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.